MD Anderson study finds lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
Patients with non-small-cell lung cancer survive longer if they are taking beta-blockers while receiving radiotherapy, according to a study of 722 patients published in the cancer journal Annals of Oncology. Researchers at the University of Texas MD Anderson Cancer Center reviewed the progress and outcomes of patients who had received radiotherapy as their main or first line of treatment for cancer.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.